Sign In
Buy THTX
$3.39
+0 (+0%)
At Close: Dec 24, 2025
Theratechnologies Inc. (THTX) CEO Paul Levesque on Q2 2021 Results - Earnings Call Transcript
01:19pm, Thursday, 15'th Jul 2021
Theratechnologies Inc. (THTX) CEO Paul Levesque on Q2 2021 Results - Earnings Call Transcript
Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings
07:56am, Thursday, 15'th Jul 2021
Theratechnologies Inc (NASDAQ: THTX) has completed discussions with the FDA and European Medicines Agency regarding its proposed trial design and protocol for its Phase 3 trial for tesamorelin in n
MONTREAL, July 15, 2021 (GLOBE NEWSWIRE) -- Theratechnologies, Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercializati
CORRECTION: Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021
11:28am, Wednesday, 30'th Jun 2021
MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- In a release issued this morning, Wednesday, June 30, 2021, under the same headline, by Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), please note that i
Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021
07:30am, Wednesday, 30'th Jun 2021
MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovat
Theratechnologies Appoints New Board Member
07:30am, Wednesday, 23'rd Jun 2021
MONTREAL, June 23, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovat
Theratechnologies Peptide-Drug Conjugate Shows Better Anti-Metastatic Activity Compared With Docetaxel Alone
11:38am, Monday, 21'st Jun 2021
Theratechnologies Inc (NASDAQ: THTX) has announced new preclinical in vivo findings on its peptide-drug conjugate (PDC), TH1902. The results demonstrate that TH1902 has better anti-metastatic activ
Theratechnologies Hires Vice President, Human Resources
08:00am, Monday, 31'st May 2021
MONTREAL, May 31, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or the Company (TSX: TH) (NASDAQ: THTX)), a biopharmaceutical company focused on the development and commercializa
100% of patients expressed satisfaction with treatment experience
Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021
09:24am, Tuesday, 18'th May 2021
MONTREAL, May 18, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovati
Announcements in Conjunction With Theratechnologies Annual Meeting
11:15am, Thursday, 13'th May 2021
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization
Theratechnologies Inc. (THTX) CEO Paul Levesque on Q1 2021 Results - Earnings Call Transcript
11:42am, Wednesday, 14'th Apr 2021
Theratechnologies Inc. (THTX) CEO Paul Levesque on Q1 2021 Results - Earnings Call Transcript
Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
07:30am, Wednesday, 14'th Apr 2021
MONTREAL, April 14, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercializati
Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference
04:30pm, Monday, 12'th Apr 2021
MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innova
Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021
01:46pm, Monday, 12'th Apr 2021
MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innova
